Healthcare provider profile · identity verified

Elizabeth Ellen Smith, M.D.

Family Practice · MESA, AZ · NPI 1952694036

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	340	101
Lisinopril	Lisinopril	273	81
Atorvastatin Calcium	Atorvastatin Calcium	264	81
Amlodipine Besylate	Amlodipine Besylate	195	53
Losartan Potassium	Losartan Potassium	187	54
Famotidine	Famotidine	159	47
Omeprazole	Omeprazole	143	43
Gabapentin	Gabapentin	135	43
Pantoprazole Sodium	Pantoprazole Sodium	134	48
Metformin Hcl	Metformin Hcl	133	41
Simvastatin	Simvastatin	110	34
Alprazolam	Alprazolam	109	30
Rosuvastatin Calcium	Rosuvastatin Calcium	108	33
Trazodone Hcl	Trazodone Hcl	91	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	90	15
Albuterol Sulfate Hfa	Albuterol Sulfate	84	30
Hydrochlorothiazide	Hydrochlorothiazide	81	28
Montelukast Sodium	Montelukast Sodium	78	27
Zolpidem Tartrate	Zolpidem Tartrate	76	16
Fluoxetine Hcl	Fluoxetine Hcl	73	22
Metformin Hcl Er	Metformin Hcl	62	18
Tramadol Hcl	Tramadol Hcl	61	16
Pravastatin Sodium	Pravastatin Sodium	60	19
Fluticasone Propionate	Fluticasone Propionate	58	26
Eliquis	Apixaban	57	suppressed
Ozempic	Semaglutide	57	suppressed
Furosemide	Furosemide	56	20
Metoprolol Succinate	Metoprolol Succinate	56	18
Meloxicam	Meloxicam	53	21
Carvedilol	Carvedilol	52	13
Duloxetine Hcl	Duloxetine Hcl	51	12
Allopurinol	Allopurinol	50	16
Januvia	Sitagliptin Phosphate	49	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	49	suppressed
Potassium Chloride	Potassium Chloride	49	20
Jardiance	Empagliflozin	46	suppressed
Lorazepam	Lorazepam	45	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	45	16
Metoprolol Tartrate	Metoprolol Tartrate	44	16
Sumatriptan Succinate	Sumatriptan Succinate	44	suppressed
Citalopram Hbr	Citalopram Hydrobromide	43	11
Tizanidine Hcl	Tizanidine Hcl	43	21
Oxycodone Hcl	Oxycodone Hcl	42	suppressed
Azelastine Hcl	Azelastine Hcl	40	24
Estradiol	Estradiol	40	16
Spironolactone	Spironolactone	40	suppressed
Sertraline Hcl	Sertraline Hcl	39	11
Triamcinolone Acetonide	Triamcinolone Acetonide	39	17
Glipizide Er	Glipizide	38	12
Prednisone	Prednisone	37	18
Diclofenac Sodium	Diclofenac Sodium	35	19
Cephalexin	Cephalexin	34	20
Trulicity	Dulaglutide	34	suppressed
Celecoxib	Celecoxib	33	12
Naproxen	Naproxen	33	12
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Ibuprofen	Ibuprofen	32	12
Methocarbamol	Methocarbamol	32	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	31	suppressed
Mounjaro	Tirzepatide	31	suppressed
Breo Ellipta	Fluticasone/Vilanterol	30	suppressed
Fluconazole	Fluconazole	30	15
Glimepiride	Glimepiride	29	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Rybelsus	Semaglutide	28	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	27	12
Eszopiclone	Eszopiclone	27	suppressed
Synthroid	Levothyroxine Sodium	27	suppressed
Atenolol	Atenolol	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Bupropion Xl	Bupropion Hcl	25	suppressed
Donepezil Hcl	Donepezil Hcl	25	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	25	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	24	18
Baclofen	Baclofen	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Lovastatin	Lovastatin	22	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	21	15
Olmesartan Medoxomil	Olmesartan Medoxomil	21	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	21	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	20	suppressed
Clonazepam	Clonazepam	20	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	20	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	20	suppressed
Clopidogrel	Clopidogrel Bisulfate	19	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	19	suppressed
Glipizide	Glipizide	19	suppressed
Ondansetron Odt	Ondansetron	19	11
Buspirone Hcl	Buspirone Hcl	18	suppressed
Farxiga	Dapagliflozin Propanediol	18	suppressed
Solifenacin Succinate	Solifenacin Succinate	18	suppressed
Alendronate Sodium	Alendronate Sodium	17	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Azithromycin	Azithromycin	16	13
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	16	suppressed
Propranolol Hcl	Propranolol Hcl	16	suppressed
Tradjenta	Linagliptin	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Mupirocin	Mupirocin	15	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	14	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	14	suppressed
Finasteride	Finasteride	13	suppressed
Methylprednisolone	Methylprednisolone	13	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	13	13
Sucralfate	Sucralfate	13	suppressed
Testosterone	Testosterone	13	suppressed
Acyclovir	Acyclovir	12	suppressed
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	12	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	12	12
Estradiol (Twice Weekly)	Estradiol	12	suppressed
Ropinirole Hcl	Ropinirole Hcl	12	suppressed
Warfarin Sodium	Warfarin Sodium	12	suppressed
Chlorthalidone	Chlorthalidone	11	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Fenofibrate	Fenofibrate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error